Rami Akhrass, MD,1 Marc Gillinov,
MD,1 Faisal Bakaeen, MD,1 Deena
Akras,1 Scott J. Cameron, MD, PhD,2Jay Bishop, MD,2 Samir Kapadia, MD,2and Lars Svensson, MD, PhD1
1 Department of Thoracic and Cardiovascular
Surgery, 2Department of Cardiovascular Medicine,
Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland.
Ohio.
Funding: There was no financial support for this study.
Disclosures: All authors declare no conflicts of interest except: Dr.
Bishop is on speaker bureau for Janssen and Dr. Gillinov is consultant
to Edwards Lifesciences, Medtronic, Abbott, CryoLife, AtriCure, Johnson
and Johnson, ClearFlow and has the right to equity from ClearFlow.
Word count: 3,398
Address for correspondence:
Rami Akhrass, MD
Department of Thoracic and Cardiovascular Surgery
Heart, Vascular and Thoracic Institute
9500 Euclid Avenue
Cleveland, Ohio 44195
akhrasr@ccf.org